ResearcherCan-Fite BioPharmaActive in the last 2 years

Michael H Silverman

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers: 0
Trials: 1
Grants: 0
Labs led: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 trial

Trials 1

Namodenoson Treatment of Advanced Pancreatic Cancer Study director NCT06387342 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Salomon Marcello Stemmer · 1 shared trial, 2024 · strength 0.68
- Trial Namodenoson Treatment of Advanced Pancreatic Cancer NCT06387342 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.